Merck & Co., Inc. Additional Paid-in Capital 2008-2026 | MRK
Beta
What is Merck & Co., Inc.'s current additional paid-in capital?
Merck & Co., Inc. (MRK) annual additional paid-in capital for 2025 was $45.03B, a 0.73% increase from 2024. Merck & Co., Inc. additional paid-in capital for the quarter ending March 31, 2026 was $45.18B.
What was Merck & Co., Inc.'s additional paid-in capital in 2024?
Merck & Co., Inc. annual additional paid-in capital for 2024 was $44.70B, a 0.44% increase from 2023.
What was Merck & Co., Inc.'s additional paid-in capital in 2023?
Merck & Co., Inc. annual additional paid-in capital for 2023 was $44.51B, a 0.29% increase from 2022.
What is Merck & Co., Inc.'s 5-year additional paid-in capital CAGR?
Merck & Co., Inc. additional paid-in capital grew at a compound annual growth rate (CAGR) of 2.61% from FY2020 to FY2025, going from $39.59B to $45.03B over 5 years.
Additional Paid-in Capital History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+2.6%
FY2020
$39.59B
→
FY2025
$45.03B
080910111213141516171819202122232425
5 years selected
Additional Paid-in Capital History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $45.03B | +0.7% | 10-K |
| FY2024 | $44.70B | +0.4% | 10-K |
| FY2023 | $44.51B | +0.3% | 10-K |
| FY2022 | $44.38B | +0.3% | 10-K |
| FY2021 | $44.24B | +11.7% | 10-K |
| FY2020 | $39.59B | -0.2% | 10-K |
| FY2019 | $39.66B | +2.2% | 10-K |
| FY2018 | $38.81B | -2.7% | 10-K |
| FY2017 | $39.90B | -0.1% | 10-K |
| FY2016 | $39.94B | -0.7% | 10-K |
| FY2015 | $40.22B | -0.5% | 10-K |
| FY2014 | $40.42B | -0.2% | 10-K |
| FY2013 | $40.51B | -0.3% | 10-K |
| FY2012 | $40.65B | -0.0% | 10-K |
| FY2011 | $40.66B | -0.1% | 10-K |
| FY2010 | $40.70B | +2.6% | 10-K |
| FY2009 | $39.68B | +377.0% | 10-K |
| FY2008 | $8.32B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →